Back
Merck KGaA Quote, Financials, Valuation and Earnings
Sponsored
MKGAF
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
19
MKGAF
Merck KGaA
Last Price:
162.15
Seasonality Move:
4.75%
7 Day Trial
ALL ACCESS PASS
$
7
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right hereMerck KGaA Price Quote
$162.15
+1.15 (+0.71%)
(Updated: May 1, 2024 at 10:40 AM ET)
Merck KGaA Key Stats
Sell
19
Merck KGaA (MKGAF)
is a Sell
Day range:
$161.00 - $162.29
52-week range:
$143.46 - $186.41
Dividend yield:
1.46%
P/E ratio:
22.91
P/S ratio:
3.08
P/B ratio:
2.37%
Volume:
56
Avg. volume:
919
1-year change:
-11.29%
Market cap:
$70B
Revenue:
$22.7B
EPS:
$7.03
How Much Does Merck KGaA Make?
-
How Much Are Merck KGaA's Sales Annually?
MKGAF Revenues are $22.7B -
How Much Profit Does Merck KGaA's Make A Year?
MKGAF net income is $3.1B
Is Merck KGaA Growing As A Company?
-
What Is Merck KGaA's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.03% -
What Is Merck KGaA's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.07%
Merck KGaA Stock Price Performance
-
Did Merck KGaA Stock Go Up Last Month?
Merck KGaA share price went down by -8.94% last month -
Did MKGAF's Share Price Rise Over The Last Year?
MKGAF share price fell by -11.29% over the past 1 year
What Is Merck KGaA 52-Week High & Low?
-
What Is Merck KGaA’s 52-Week High Share Price?
Merck KGaA has traded as high as $186.41 over the past 52 weeks -
What Is Merck KGaA’s 52-Week Low Share Price?
Merck KGaA has traded as low as $143.46 over the past 52 weeks
Merck KGaA Price To Free Cash Flow
-
Is Merck KGaA Stock Overvalued?
Merck KGaA is trading at a price to free cash flow ratio of 36.73 -
Is Merck KGaA Stock Undervalued?
Merck KGaA EV to Free Cash Flow ratio is 41.02 -
What Is Merck KGaA’s Price Earnings Growth Ratio?
MKGAF PEG ratio is 0.00 -
Is Merck KGaA Trading At A Premium To Earnings?
Merck KGaA EV to EBIT ratio is 18.90
Is It Risky To Buy Merck KGaA?
-
How Much Debt Does Merck KGaA Have?
Total long term debt quarterly is $10.3B -
How Much Cash Does Merck KGaA Have?
Cash and short term investments quarterly total is $2.2B -
What Is Merck KGaA’s Book Value Per Share?
Book value per share is 67.83
Is Merck KGaA Cash Flow Positive?
-
What Is MKGAF Cash Flow From Operations?
Cash flow from operations (TTM) is $4.1B -
What Is Merck KGaA’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.9B -
What Is Merck KGaA’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2B
Merck KGaA Return On Invested Capital
-
Is Management Doing A Good Job?
MKGAF return on invested capital is 7.59% -
What Is Merck KGaA Return On Assets?
ROA measures how assets are converting to revenues and is 5.78% -
What Is MKGAF Return On Equity?
ROE is a measure of profitability and is 10.54%
Merck KGaA Earnings Date & Stock Price
-
What Is Merck KGaA's Stock Price Today?
A single share of MKGAF can be purchased today for 161.00 -
What Is Merck KGaA’s Stock Symbol?
Merck KGaA trades on the otcm under the ticker symbol: MKGAF -
When Is Merck KGaA’s Next Earnings Date?
The next quarterly earnings date for Merck KGaA is scheduled on May 15, 2024 -
When Is MKGAF's next ex-dividend date?
Merck KGaA's next ex-dividend date is April 29, 2024 -
How To Buy Merck KGaA Stock?
You can buy Merck KGaA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Merck KGaA Competitors
-
Who Are Merck KGaA's Competitors?
Below is a list of companies who compete with Merck KGaA or are related in some way:
Merck KGaA Dividend Yield
-
What Is MKGAF Dividend Yield?
Merck KGaA’s dividend yield currently is 1.46% -
What Is Merck KGaA’s Payout Ratio?
Merck KGaA’s payout ratio is 10.05% -
When Did Merck KGaA Last Pay A Dividend?
The latest dividend pay date is May 1, 2024 -
What Is Merck KGaA’s Dividend Per Share?
Merck KGaA pays a dividend of $0.00 per share
Merck KGaA Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -6.54% | 0% |
Revenue: | -2.78% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |